Polypharmacy in patients with cardiovascular disease occurs frequently across the age spectrum and can lead to inappropriate prescribing and adverse outcomes. Despite polypharmacy being a known ...
The proposed OMB changes to research funding threaten US science. Researchers must stand up for and share the value of science to society.